Cassava Sciences Inc vs VanEck Australian Floating Rate ETF — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while VanEck Australian Floating Rate ETF trades at $50.93. The key difference: VanEck Australian Floating Rate ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | FLOT | |
|---|---|---|
Market Cap | $47.75M | — |
Sector | Health | Sector/Thematic |
52-Week High | $4.64 | $51.09 |
52-Week Low | $0.87 | $50.72 |
Enterprise Value | -$34.93M | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FLOT, the iShares Floating Rate Bond ETF, trades at $50.93, showing minimal daily movement. The technical outlook is bearish based on moving averages, though oscillators are neutral. Recent news highlights its role as a potential hedge against rising interest rates, with a focus on high credit quality and a 4.0% SEC yield. Dividend payments are consistent, with recent distributions around $0.17-$0.18 per share.
The outlook for FLOT is cautiously positive if the Federal Reserve raises rates, as its floating rate structure could benefit income growth. Risks include credit quality deterioration and persistent inflation without Fed action. Analyst sentiment is generally neutral, viewing it as a stable short-term cash alternative rather than a growth vehicle.
Trailing returns across standard periods
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →FLOT provides exposure to a diversified portfolio of Australian dollar-denominated floating rate notes. It tracks the Bloomberg AusBond Credit FRN 0+ Yr Index, focusing on high-quality, investment-grade bonds from top Australian banks and financial institutions.
Read more on FLOT →